Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma

This study uses data from the National Cancer Database to examine the population-level efficacy of novel therapies for advanced-stage melanoma.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Sinnamon, Andrew J., Neuwirth, Madalyn G., Gimotty, Phyllis A., Gangadhar, Tara C., Amaravadi, Ravi K., Schuchter, Lynn M., Karakousis, Giorgos C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833649/
https://ncbi.nlm.nih.gov/pubmed/29145547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.3462
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados